Form Filed By Behbahani Ali
Fri, Jun 20, 2025
Go to original document
Black Diamond Therapeutics, Inc. (BDTX)
Healthcare
Biotechnology
Insights
Coming soon
Non Derivative Transactions
2025-06-20
Common Stock
Award
A
Type
Acquired 6,170 shares @ $2.33 per share
77,150 shares
Direct
Common Stock
Other
Type
Disposed 0 shares @ $0.00 per share
4,448,757 shares
See Note 3
Indirect
Footnotes
1. These shares were issued in accordance with the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
2. The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on June 18, 2025.
3. The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Reporting Person has no pecuniary interest.